Pharmacophore-based discovery of a novel cytosolic phospholipase A2α inhibitor
Open Access
- 1 January 2012
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (2) , 1202-1207
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniquesBioorganic & Medicinal Chemistry Letters, 2011
- Pharmacophores in Drug ResearchMolecular Informatics, 2010
- Morphinans and isoquinolines: Acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptorsBioorganic & Medicinal Chemistry, 2010
- 1-(5-Carboxyindol-1-yl)propan-2-one Inhibitors of Human Cytosolic Phospholipase A2α with Reduced Lipophilicity: Synthesis, Biological Activity, Metabolic Stability, Solubility, Bioavailability, And Topical in Vivo ActivityJournal of Medicinal Chemistry, 2010
- Advances in eicosanoid research, novel therapeutic implicationsBiochemical and Biophysical Research Communications, 2010
- Phospholipase A2 structure/function, mechanism, and signalingJournal of Lipid Research, 2009
- Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate CancerClinical Cancer Research, 2008
- In vitroallergen challenge of peripheral blood induces differential gene expression in mononuclear cells of asthmatic patients: inhibition of cytosolic phospholipase A2αovercomes the asthma‐associated responseClinical & Experimental Allergy, 2008
- 1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2α: Synthesis, biological activity, metabolic stability, and solubilityBioorganic & Medicinal Chemistry, 2008
- Virtual Screening Workflow Development Guided by the “Receiver Operating Characteristic” Curve Approach. Application to High-Throughput Docking on Metabotropic Glutamate Receptor Subtype 4Journal of Medicinal Chemistry, 2005